跳至主要内容
临床试验/IRCT20150919024080N16
IRCT20150919024080N16招募中3 期

The effect of hydroalcoholic rosemary extract on cognitive function? pulmonary function and physical activity daily of living of patients with chronic obstructive pulmonary disease

Khoram-Abad University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • Age between 40 and 80 years
  • The ratio of FEV1 to FVC is less than 0.7 exhalation pressure volume per second (FEV1)?less than 70% of reference value and increase in FEV1 less than 10% after inhalation of beta-two agonists
  • Detection of COPD based on grade one to three gold criteria approved by spirometry and physician
  • Patients with mild to moderate cognitive impairment based on MMSE test with a minimum score of 23
  • Have a history of smoking at least ten packs of cigarettes a year
  • At least one year has passed since the diagnosis of COPD in the patient
  • Do not take any herbal medicine supplements effective in improving cognitive function and lung function and daily activity (such as Ginseng?Thyme?Nigella sativa?Chamomile?etc)from two months ago
  • No alcohol?hookah and drugs
  • Do not take antioxidants as a supplement during the last three months(vitamin E?Omega3?a-tocopherol?etc)

排除标准

  • Lack of motivation of the patient to continue cooperation
  • Hospitalization during the study
  • Neurological disease?cancer?acute infection and known mental disorders(anxiety?depression and delirium)
  • Patient deterioration?unstable hemodynamic status?life threatening arrhythmias
  • Participate in other pulmonary rehabilitation programs or meditation and yoga
  • Do not take the capsules for two consecutive days
  • Demonstrate sensitivity to capsules
  • If the patient needs to take drugs that affect cognitive or pulmonary function or the amount of daily activity (such as muscle relaxants?etc)during the study?in addition to the main treatment drugs?excluded from the study
  • Patients receiving vasodilators include organic nitrates and people with pulmonary ?hypertension?obstructive sleep apnea?malignancies?gastrointestinal abnormalities?recent surgery?severe endocrine disease?kidney disease?liver disease?inflammatory and infectious disease?and musculoskeletal disease active that causes impairment in exercise and respiratory capacity

研究者

发起方
Khoram-Abad University of Medical Sciences

相似试验